The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global BioPharmaceutical Tubing Market Research Report 2025

Global BioPharmaceutical Tubing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1600409

No of Pages : 99

Ask Your Query

Synopsis

BioPharmaceutical Tubing designed to meet the critical demands of pharmaceutical and biopharmaceutical applications for fluid processing.

The global BioPharmaceutical Tubing market was valued at US$ 2013.2 million in 2023 and is anticipated to reach US$ 2526.9 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for BioPharmaceutical Tubing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharmaceutical Tubing.

Report Scope

The BioPharmaceutical Tubing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BioPharmaceutical Tubing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the BioPharmaceutical Tubing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Zeus Industrial Products
  • Saint-Gobain Performance Plastics
  • Teleflex
  • Optinova
  • Lubrizol Corporation
  • Nordson Corporation
  • Putnam Plastics
  • Tekni-Plex
  • RAUMEDIC AG
  • W. L. Gore & Associates
  • Saint-Gobain
  • Watson-Marlow
  • Cole-Parmer
  • AdvantaPure
  • Moldex Metric
  • Trelleborg Sealing Solutions
  • Merck Millipore

Segment by Type

  • Plastics
  • Metals
  • Silicone

Segment by Application

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Medical Labs
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BioPharmaceutical Tubing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BioPharmaceutical Tubing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 BioPharmaceutical Tubing Market Overview
1.1 Product Overview and Scope of BioPharmaceutical Tubing
1.2 BioPharmaceutical Tubing Segment by Type
1.2.1 Global BioPharmaceutical Tubing Market Value Comparison by Type (2024-2030)
1.2.2 Plastics
1.2.3 Metals
1.2.4 Silicone
1.3 BioPharmaceutical Tubing Segment by Application
1.3.1 Global BioPharmaceutical Tubing Market Value by Application: (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Medical Labs
1.3.5 Others
1.4 Global BioPharmaceutical Tubing Market Size Estimates and Forecasts
1.4.1 Global BioPharmaceutical Tubing Revenue 2019-2030
1.4.2 Global BioPharmaceutical Tubing Sales 2019-2030
1.4.3 Global BioPharmaceutical Tubing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 BioPharmaceutical Tubing Market Competition by Manufacturers
2.1 Global BioPharmaceutical Tubing Sales Market Share by Manufacturers (2019-2024)
2.2 Global BioPharmaceutical Tubing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global BioPharmaceutical Tubing Average Price by Manufacturers (2019-2024)
2.4 Global BioPharmaceutical Tubing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BioPharmaceutical Tubing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BioPharmaceutical Tubing, Product Type & Application
2.7 BioPharmaceutical Tubing Market Competitive Situation and Trends
2.7.1 BioPharmaceutical Tubing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BioPharmaceutical Tubing Players Market Share by Revenue
2.7.3 Global BioPharmaceutical Tubing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BioPharmaceutical Tubing Retrospective Market Scenario by Region
3.1 Global BioPharmaceutical Tubing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global BioPharmaceutical Tubing Global BioPharmaceutical Tubing Sales by Region: 2019-2030
3.2.1 Global BioPharmaceutical Tubing Sales by Region: 2019-2024
3.2.2 Global BioPharmaceutical Tubing Sales by Region: 2025-2030
3.3 Global BioPharmaceutical Tubing Global BioPharmaceutical Tubing Revenue by Region: 2019-2030
3.3.1 Global BioPharmaceutical Tubing Revenue by Region: 2019-2024
3.3.2 Global BioPharmaceutical Tubing Revenue by Region: 2025-2030
3.4 North America BioPharmaceutical Tubing Market Facts & Figures by Country
3.4.1 North America BioPharmaceutical Tubing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America BioPharmaceutical Tubing Sales by Country (2019-2030)
3.4.3 North America BioPharmaceutical Tubing Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe BioPharmaceutical Tubing Market Facts & Figures by Country
3.5.1 Europe BioPharmaceutical Tubing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe BioPharmaceutical Tubing Sales by Country (2019-2030)
3.5.3 Europe BioPharmaceutical Tubing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BioPharmaceutical Tubing Market Facts & Figures by Country
3.6.1 Asia Pacific BioPharmaceutical Tubing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific BioPharmaceutical Tubing Sales by Country (2019-2030)
3.6.3 Asia Pacific BioPharmaceutical Tubing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America BioPharmaceutical Tubing Market Facts & Figures by Country
3.7.1 Latin America BioPharmaceutical Tubing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America BioPharmaceutical Tubing Sales by Country (2019-2030)
3.7.3 Latin America BioPharmaceutical Tubing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BioPharmaceutical Tubing Market Facts & Figures by Country
3.8.1 Middle East and Africa BioPharmaceutical Tubing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa BioPharmaceutical Tubing Sales by Country (2019-2030)
3.8.3 Middle East and Africa BioPharmaceutical Tubing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global BioPharmaceutical Tubing Sales by Type (2019-2030)
4.1.1 Global BioPharmaceutical Tubing Sales by Type (2019-2024)
4.1.2 Global BioPharmaceutical Tubing Sales by Type (2025-2030)
4.1.3 Global BioPharmaceutical Tubing Sales Market Share by Type (2019-2030)
4.2 Global BioPharmaceutical Tubing Revenue by Type (2019-2030)
4.2.1 Global BioPharmaceutical Tubing Revenue by Type (2019-2024)
4.2.2 Global BioPharmaceutical Tubing Revenue by Type (2025-2030)
4.2.3 Global BioPharmaceutical Tubing Revenue Market Share by Type (2019-2030)
4.3 Global BioPharmaceutical Tubing Price by Type (2019-2030)
5 Segment by Application
5.1 Global BioPharmaceutical Tubing Sales by Application (2019-2030)
5.1.1 Global BioPharmaceutical Tubing Sales by Application (2019-2024)
5.1.2 Global BioPharmaceutical Tubing Sales by Application (2025-2030)
5.1.3 Global BioPharmaceutical Tubing Sales Market Share by Application (2019-2030)
5.2 Global BioPharmaceutical Tubing Revenue by Application (2019-2030)
5.2.1 Global BioPharmaceutical Tubing Revenue by Application (2019-2024)
5.2.2 Global BioPharmaceutical Tubing Revenue by Application (2025-2030)
5.2.3 Global BioPharmaceutical Tubing Revenue Market Share by Application (2019-2030)
5.3 Global BioPharmaceutical Tubing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zeus Industrial Products
6.1.1 Zeus Industrial Products Corporation Information
6.1.2 Zeus Industrial Products Description and Business Overview
6.1.3 Zeus Industrial Products BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zeus Industrial Products BioPharmaceutical Tubing Product Portfolio
6.1.5 Zeus Industrial Products Recent Developments/Updates
6.2 Saint-Gobain Performance Plastics
6.2.1 Saint-Gobain Performance Plastics Corporation Information
6.2.2 Saint-Gobain Performance Plastics Description and Business Overview
6.2.3 Saint-Gobain Performance Plastics BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Saint-Gobain Performance Plastics BioPharmaceutical Tubing Product Portfolio
6.2.5 Saint-Gobain Performance Plastics Recent Developments/Updates
6.3 Teleflex
6.3.1 Teleflex Corporation Information
6.3.2 Teleflex Description and Business Overview
6.3.3 Teleflex BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teleflex BioPharmaceutical Tubing Product Portfolio
6.3.5 Teleflex Recent Developments/Updates
6.4 Optinova
6.4.1 Optinova Corporation Information
6.4.2 Optinova Description and Business Overview
6.4.3 Optinova BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Optinova BioPharmaceutical Tubing Product Portfolio
6.4.5 Optinova Recent Developments/Updates
6.5 Lubrizol Corporation
6.5.1 Lubrizol Corporation Corporation Information
6.5.2 Lubrizol Corporation Description and Business Overview
6.5.3 Lubrizol Corporation BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lubrizol Corporation BioPharmaceutical Tubing Product Portfolio
6.5.5 Lubrizol Corporation Recent Developments/Updates
6.6 Nordson Corporation
6.6.1 Nordson Corporation Corporation Information
6.6.2 Nordson Corporation Description and Business Overview
6.6.3 Nordson Corporation BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nordson Corporation BioPharmaceutical Tubing Product Portfolio
6.6.5 Nordson Corporation Recent Developments/Updates
6.7 Putnam Plastics
6.6.1 Putnam Plastics Corporation Information
6.6.2 Putnam Plastics Description and Business Overview
6.6.3 Putnam Plastics BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Putnam Plastics BioPharmaceutical Tubing Product Portfolio
6.7.5 Putnam Plastics Recent Developments/Updates
6.8 Tekni-Plex
6.8.1 Tekni-Plex Corporation Information
6.8.2 Tekni-Plex Description and Business Overview
6.8.3 Tekni-Plex BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tekni-Plex BioPharmaceutical Tubing Product Portfolio
6.8.5 Tekni-Plex Recent Developments/Updates
6.9 RAUMEDIC AG
6.9.1 RAUMEDIC AG Corporation Information
6.9.2 RAUMEDIC AG Description and Business Overview
6.9.3 RAUMEDIC AG BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAUMEDIC AG BioPharmaceutical Tubing Product Portfolio
6.9.5 RAUMEDIC AG Recent Developments/Updates
6.10 W. L. Gore & Associates
6.10.1 W. L. Gore & Associates Corporation Information
6.10.2 W. L. Gore & Associates Description and Business Overview
6.10.3 W. L. Gore & Associates BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 W. L. Gore & Associates BioPharmaceutical Tubing Product Portfolio
6.10.5 W. L. Gore & Associates Recent Developments/Updates
6.11 Saint-Gobain
6.11.1 Saint-Gobain Corporation Information
6.11.2 Saint-Gobain BioPharmaceutical Tubing Description and Business Overview
6.11.3 Saint-Gobain BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Saint-Gobain BioPharmaceutical Tubing Product Portfolio
6.11.5 Saint-Gobain Recent Developments/Updates
6.12 Watson-Marlow
6.12.1 Watson-Marlow Corporation Information
6.12.2 Watson-Marlow BioPharmaceutical Tubing Description and Business Overview
6.12.3 Watson-Marlow BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Watson-Marlow BioPharmaceutical Tubing Product Portfolio
6.12.5 Watson-Marlow Recent Developments/Updates
6.13 Cole-Parmer
6.13.1 Cole-Parmer Corporation Information
6.13.2 Cole-Parmer BioPharmaceutical Tubing Description and Business Overview
6.13.3 Cole-Parmer BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cole-Parmer BioPharmaceutical Tubing Product Portfolio
6.13.5 Cole-Parmer Recent Developments/Updates
6.14 AdvantaPure
6.14.1 AdvantaPure Corporation Information
6.14.2 AdvantaPure BioPharmaceutical Tubing Description and Business Overview
6.14.3 AdvantaPure BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AdvantaPure BioPharmaceutical Tubing Product Portfolio
6.14.5 AdvantaPure Recent Developments/Updates
6.15 Moldex Metric
6.15.1 Moldex Metric Corporation Information
6.15.2 Moldex Metric BioPharmaceutical Tubing Description and Business Overview
6.15.3 Moldex Metric BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Moldex Metric BioPharmaceutical Tubing Product Portfolio
6.15.5 Moldex Metric Recent Developments/Updates
6.16 Trelleborg Sealing Solutions
6.16.1 Trelleborg Sealing Solutions Corporation Information
6.16.2 Trelleborg Sealing Solutions BioPharmaceutical Tubing Description and Business Overview
6.16.3 Trelleborg Sealing Solutions BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Trelleborg Sealing Solutions BioPharmaceutical Tubing Product Portfolio
6.16.5 Trelleborg Sealing Solutions Recent Developments/Updates
6.17 Merck Millipore
6.17.1 Merck Millipore Corporation Information
6.17.2 Merck Millipore BioPharmaceutical Tubing Description and Business Overview
6.17.3 Merck Millipore BioPharmaceutical Tubing Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Merck Millipore BioPharmaceutical Tubing Product Portfolio
6.17.5 Merck Millipore Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BioPharmaceutical Tubing Industry Chain Analysis
7.2 BioPharmaceutical Tubing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BioPharmaceutical Tubing Production Mode & Process
7.4 BioPharmaceutical Tubing Sales and Marketing
7.4.1 BioPharmaceutical Tubing Sales Channels
7.4.2 BioPharmaceutical Tubing Distributors
7.5 BioPharmaceutical Tubing Customers
8 BioPharmaceutical Tubing Market Dynamics
8.1 BioPharmaceutical Tubing Industry Trends
8.2 BioPharmaceutical Tubing Market Drivers
8.3 BioPharmaceutical Tubing Market Challenges
8.4 BioPharmaceutical Tubing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock